- RESEARCH PROFESSOR Preventive Medicine
B.Sc., Ph.D., University of Birmingham
- Professor Todd came to Mount Sinai as an Assistant Professor in 1992. He is also an Adjunct Associate Professor in the Bloomberg School of Public Health at Johns Hopkins University in Baltimore, MD. Prof. Todd was formerly a Visiting Professor at The University of Maryland (Baltimore), Program in Toxicology, where he worked with Drs. B.A. Fowler and E.K. Silbergeld. Prof. Todd trained at the University of Birmingham (England), under the supervision of Dr. D.R. Chettle. Prof. Todd's Ph.D. thesis title was "The In Vivo measurement of Lead and Platinum in the Kidney" (1989); a study of the pharmacodynamics of the chemotherapeutic drug cisplatinum, performed using the non invasive technique of X-Ray Fluorescence. Since then, Prof. Todd has used the same XRF technique to measure the bone lead (Pb) concentrations (a measure of cumulative lead exposure) of several thousand research subjects, volunteers, workers and referrals, for several federally funded research studies. Prof. Todd's current scientific work covers all aspects of in vivo bone measurements in both national and international arenas. Prof. Todd has also reviewed for Environmental Research, American Public Health Association, Medical Physics, Journal of the American Medical Association, Environmental Health Perspectives and is a Contributing Editor to the American Journal of Industrial Medicine.
Prof. Todd is also the Senior Systems Analyst for the Data Management Core of the World Trade Center Health Program Data Center at Mount Sinai; a program that provides free, annual medical examinations and treatment for approximately 30,000 workers and volunteers who were involved in the World Trade Center rescue and recovery effort.
Prof. Todd also works with the International Association of Heat and Frost Insulators & Allied Workers, to realize their vision of a tissue bank of high quality specimens to accelerate research into the diagnosis and cure of the devastating diseases resulting from asbestos exposure.
Bone Lead MeasurementsProf. Todd directs the Bone Lead X-Ray Fluorescence Laboratory (in the Department of Preventive Medicine at Mount Sinai) which is one of the country's leading centers for a novel technique for measuring long-term lead exposure. This facility has measured people for over a dozen federally funded research studies and measures people who are referred by physicians because they have symptoms of lead toxicity or are concerned about lead exposure they may have suffered in the past. The information obtained from bone lead measurements can provide evidence of historical lead exposure, in the absence of documented exposure. For more information about bone lead testing, please visit X-Ray Fluorescence Bone Lead Testing Facility
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Todd did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
17 East 102 Street Floor W. Tower, 2nd floor Room 133
New York, NY 10029